Spots Global Cancer Trial Database for lymphocytic leukemia
Every month we try and update this database with for lymphocytic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy | NCT00108108 | Chronic Lymphoc... | HCD122 | 18 Years - | Novartis | |
| Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies | NCT00013533 | Hodgkin Lymphom... Lymphocytic Leu... Mixed Cell Leuk... Myelodysplastic... Non Hodgkin's L... CML ALL AML Lymphoma | Stem cell trans... | 4 Years - 20 Years | National Institutes of Health Clinical Center (CC) | |
| Effect of Product Related Factors on Platelet Concentrate Transfusion Response in Patients With Hematologic Malignacies | NCT02885038 | Lymphoma Multiple Myelom... Lymphocytic Leu... Hodgkin Disease | Platelet concen... | 18 Years - | Etablissement Français du Sang | |
| Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT02556346 | Chronic B-cell ... Small Lymphocyt... | MT-3724 MT-3724 MT-3724 MT-3724 MT-3724 | 18 Years - | Molecular Templates, Inc. | |
| Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease | NCT01174940 | Stem Cell Leuke... Graft Versus Ho... | extracorporeal ... | 18 Years - | University of Kansas Medical Center | |
| A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | NCT02556892 | Lymphocytic Leu... | Ibrutinib | 20 Years - | Janssen Pharmaceutical K.K. | |
| Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies | NCT00013533 | Hodgkin Lymphom... Lymphocytic Leu... Mixed Cell Leuk... Myelodysplastic... Non Hodgkin's L... CML ALL AML Lymphoma | Stem cell trans... | 4 Years - 20 Years | National Institutes of Health Clinical Center (CC) | |
| Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease | NCT01174940 | Stem Cell Leuke... Graft Versus Ho... | extracorporeal ... | 18 Years - | University of Kansas Medical Center | |
| This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL) | NCT00517218 | Lymphocytic Leu... | Genasense® (, o... | 18 Years - | Genta Incorporated | |
| A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL. | NCT03219450 | Lymphocytic Leu... | NeoVax Cyclophosphamid... Pembrolizumab | 18 Years - | Dana-Farber Cancer Institute | |
| A Study to Investigate the Efficacy and Safety of MS-553 in CLL/SLL | NCT05272813 | Lymphocytic Leu... Small Lymphocyt... | MS-553 | 18 Years - | MingSight Pharmaceuticals, Inc | |
| Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia | NCT00464113 | Chronic Myeloid... Leukemia, Lymph... | XL228 | 18 Years - | Exelixis | |
| Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy | NCT00108108 | Chronic Lymphoc... | HCD122 | 18 Years - | Novartis | |
| Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia | NCT00464113 | Chronic Myeloid... Leukemia, Lymph... | XL228 | 18 Years - | Exelixis | |
| Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia | NCT00076180 | T-Cell Large Gr... Leukemia, T-Cel... | Hu-MiK-Beta-1 | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia | NCT00270049 | Anemia Leukemia, Lymph... Leukemia, Lymph... Cancer Neoplasms Quality of Life | epoetin alfa | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease | NCT01174940 | Stem Cell Leuke... Graft Versus Ho... | extracorporeal ... | 18 Years - | University of Kansas Medical Center | |
| Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy | NCT05065866 | Non Hodgkin Lym... Hodgkin Lymphom... Myeloma Lymphocytic Leu... | BMS-986345 Duvelisib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | NCT02556892 | Lymphocytic Leu... | Ibrutinib | 20 Years - | Janssen Pharmaceutical K.K. | |
| A Study to Investigate the Efficacy and Safety of MS-553 in CLL/SLL | NCT05272813 | Lymphocytic Leu... Small Lymphocyt... | MS-553 | 18 Years - | MingSight Pharmaceuticals, Inc | |
| Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT02556346 | Chronic B-cell ... Small Lymphocyt... | MT-3724 MT-3724 MT-3724 MT-3724 MT-3724 | 18 Years - | Molecular Templates, Inc. | |
| Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia | NCT00270049 | Anemia Leukemia, Lymph... Leukemia, Lymph... Cancer Neoplasms Quality of Life | epoetin alfa | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Effect of Product Related Factors on Platelet Concentrate Transfusion Response in Patients With Hematologic Malignacies | NCT02885038 | Lymphoma Multiple Myelom... Lymphocytic Leu... Hodgkin Disease | Platelet concen... | 18 Years - | Etablissement Français du Sang | |
| Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT00935792 | Lymphocytic Leu... | alemtuzumab everolimus | 18 Years - 120 Years | Mayo Clinic | |
| Effect of Product Related Factors on Platelet Concentrate Transfusion Response in Patients With Hematologic Malignacies | NCT02885038 | Lymphoma Multiple Myelom... Lymphocytic Leu... Hodgkin Disease | Platelet concen... | 18 Years - | Etablissement Français du Sang |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
